Dr. Elliot Brown, one of the founding Directors of PrimeVigilance, has been invited to become an honorary consultant to the WHO Uppsala Monitoring Centre.

 

PrimeVigilance is pleased to share the news that Dr. Elliot Brown, one of the founding Directors of PrimeVigilance, has been invited to become an honorary consultant to the WHO Uppsala Monitoring Centre and will join their Signal Review Panel. Dr Brown said: “I am delighted to have the opportunity of assisting the UMC in its important programme of activities supporting and promoting patient safety.”

The panel comprises clinical experts who review the results of the regular computerised screenings of ADR reports on all marketed products that have been submitted to the WHO Programme from national pharmacovigilance centres worldwide. The results of their work, consisting of a summary of available evidence, are circulated to national centres periodically in the ‘SIGNAL’ document and published in the WHO Pharmaceuticals Newsletter.

For more information please contact us at info@primevigilance.com or visit the UMC website at www.who-umc.org

Share this:

 


NEXT NEWS:

PREVIOUS NEWS:

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services